Abstract
In a normal spontaneous menstrual cycle, the luteal phase is characterized by the production and secretion of estradiol (E) and progesterone (P) from the corpus luteum (CL) in an episodic manner. The steroidogenesis of the CL is dependent on continued tonic luteinizing hormone (LH) secretion (Fritz and Speroff, Clinical gynecologic endocrinology and infertility, 8th edn. Wolters Kluwer, Lippincott Williams & Wilkins, Philadelphia, 2011). The dependence of the CL was further supported by the prompt luteolysis that followed the administration of GnRH analogues or withdrawal of GnRH when ovulation has been induced by the administration of pulsatile GnRH (Hutchison and Zeleznik, Endocrinology 115:1780–1786, 1984; Fraser et al., Hum Reprod 12:430–435, 1997). Progesterone concentrations normally rise sharply after ovulation, reaching a peak approximately 8 days after the LH surge. Since the secretion of E and P during the luteal phase is episodic and correlates closely with LH pulses, relatively low mid-luteal progesterone levels can be found in the course of a totally normal luteal phase (Fritz and Speroff, Clinical gynecologic endocrinology and infertility, 8th edn. Wolters Kluwer, Lippincott Williams & Wilkins, Philadelphia, 2011).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Fritz MA, Speroff L (2011) Clinical gynecologic endocrinology and infertility, 8th edn. Wolters Kluwer, Lippincott Williams & Wilkins, Philadelphia
Edwards RG, Steptoe PC, Purdy JM (1980) Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynaecol 87(9):737–756
Check JH et al (1987) The efficacy of progesterone in achieving successful pregnancy: I. Prophylactic use during luteal phase in anovulatory women. Int J Fertil 32(2):135–138
Check JH, Chase JS, Nowroozi K, Nazari A (1989) Ovulation induction and pregnancies in women with ovarian failure (reversing menopause). In: Parthenon publishing, recent developments in fertility & sterility, proceedings of the XIII World Congress on fertility and sterility, Marrakesh, October 1989, vol 6. pp 43–47
Kerin JF et al (1981) Human luteal phase function following oocyte aspiration from the immediately preovular graafian follicle of spontaneous ovular cycles. Br J Obstet Gynaecol 88(10):1021–1028
Tavaniotou A, Devroey P (2003) Effect of human chorionic gonadotropin on luteal luteinizing hormone concentrations in natural cycles. Fertil Steril 80(3):654–655
Smitz J et al (1992) Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Hum Reprod 7(9):1225–1229
Albano C et al (1998) The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix. Fertil Steril 70(2):357–359
Fauser BC, Devroey P (2003) Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab 14(5):236–242
Gardner DK, Weissman A, Howles CM, Shoham Z (eds) (2009) Textbook of assisted reproductive techniques laboratory and clinical perspectives, 3rd edn. Martin Dunitz, London
Leeton J, Trounson A, Jessup D (1985) Support of the luteal phase in in vitro fertilization programs: results of a controlled trial with intramuscular Proluton. J In Vitro Fert Embryo Transf 2(3):166–169
Daya S, Gunby J (2004) Luteal phase support in assisted reproduction cycles. Cochrane Database Syst Rev (3):CD004830
van der Linden M et al (2011) Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev (10):CD009154
Bourgain C et al (1990) Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod 5(5):537–543
Zarutskie PW, Phillips JA (2009) A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone. Fertil Steril 92(1):163–169
Bouckaert Y et al (2004) Acute eosinophilic pneumonia associated with intramuscular administration of progesterone as luteal phase support after IVF: case report. Hum Reprod 19(8):1806–1810
Costabile L et al (2001) A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 76(2):394–396
Pritts EA, Atwood AK (2002) Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 17(9):2287–2299
Devroey P et al (1989) Progesterone administration in patients with absent ovaries. Int J Fertil 34(3):188–193
Smitz J et al (1992) A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Hum Reprod 7(2):168–175
Miles RA et al (1994) Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril 62(3):485–490
De ZD (1995) Hormonal control of endometrial receptivity. Hum Reprod 10(1):4–7
Roman E et al (2000) Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone. Hum Reprod 15(7):1435–1439
Gurbuz B et al (2003) Bleeding patterns in women using intramuscular progesterone for luteal support in in-vitro fertilisation cycles. J Obstet Gynaecol 23(3):267–270
Zegers-Hochschild F et al (2000) Prospective randomized trial to evaluate the efficacy of a vaginal ring releasing progesterone for IVF and oocyte donation. Hum Reprod 15(10):2093–2097
Mochtar MH, Van Wely M, Van der Veen F (2006) Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles. Hum Reprod 21(4):905–908
Nyboe Andersen A et al (2002) Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. Hum Reprod 17(2):357–361
Aboulghar MA et al (2008) Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks. Hum Reprod 23(4):857–862
Fatemi HM et al (2006) Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Hum Reprod 21(10):2628–2632
Fatemi HM et al (2007) The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. Fertil Steril 87(3):504–508
Kolibianakis EM et al (2008) Estrogen addition to progesterone for luteal phase support in cycles stimulated with GnRH analogues and gonadotrophins for IVF: a systematic review and meta-analysis. Hum Reprod 23(6):1346–1354
Var T et al (2011) A comparison of the effects of three different luteal phase support protocols on in vitro fertilization outcomes: a randomized clinical trial. Fertil Steril 95(3):985–989
Humaidan P, Kol S, Papanikolaou EG, on behalf of the “the Copenhagen GnRH Agonist Triggering Workshop Group” (2011) GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 17(4):510–524
Griesinger G et al (2006) GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 12(2):159–168
Eldar-Geva T et al (2007) Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation. Reprod Biomed Online 14(2):148–154
Engmann L et al (2008) The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 89(1):84–91
Hutchison JS, Zeleznik AJ (1984) The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle. Endocrinology 115(5):1780–1786
Fraser HM et al (1997) Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge. Hum Reprod 12(3):430–435
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Or, Y., Vaisbuch, E., Shoham, Z. (2014). Luteal Phase Support in ART Treatments. In: Rosenwaks, Z., Wassarman, P. (eds) Human Fertility. Methods in Molecular Biology, vol 1154. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0659-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0659-8_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0658-1
Online ISBN: 978-1-4939-0659-8
eBook Packages: Springer Protocols